PlusPedia wird derzeit technisch modernisiert. Aktuell laufen Wartungsarbeiten. Für etwaige Unannehmlichkeiten bitten wir um Entschuldigung; es sind aber alle Artikel zugänglich und Sie können PlusPedia genauso nutzen wie immer.

Neue User bitte dringend diese Hinweise lesen:

Anmeldung - E-Mail-Adresse Neue Benutzer benötigen ab sofort eine gültige Email-Adresse. Wenn keine Email ankommt, meldet Euch bitte unter NewU25@PlusPedia.de.

Hinweis zur Passwortsicherheit:
Bitte nutzen Sie Ihr PlusPedia-Passwort nur bei PlusPedia.
Wenn Sie Ihr PlusPedia-Passwort andernorts nutzen, ändern Sie es bitte DORT bis unsere Modernisierung abgeschlossen ist.
Überall wo es sensibel, sollte man generell immer unterschiedliche Passworte verwenden! Das gilt hier und im gesamten Internet.
Aus Gründen der Sicherheit (PlusPedia hatte bis 24.07.2025 kein SSL | https://)

Bei PlusPedia sind Sie sicher: – Wir verarbeiten keine personenbezogenen Daten, erlauben umfassend anonyme Mitarbeit und erfüllen die Datenschutz-Grundverordnung (DSGVO) vollumfänglich. Es haftet der Vorsitzende des Trägervereins.

PlusPedia blüht wieder auf als freundliches deutsches Lexikon.
Wir haben auf die neue Version 1.43.3 aktualisiert.
Wir haben SSL aktiviert.
Hier geht es zu den aktuellen Aktuelle Ereignissen

Statistik und Studiendesign

Aus PlusPedia
Version vom 19. November 2024, 18:42 Uhr von Fmrauch (Diskussion | Beiträge) (wieso hat das nur mit Medizin zu tun?)
Zur Navigation springen Zur Suche springen

Statistik und Studiendesign sind wesentliche Grundlagen in vielen Bereichen wissenschaftlicher Forschung. Die gilt insbesondere in den Naturwissenschaften.

Siehe auch
Freie Übersichtsartikel

[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74]

Bibliographie

  1. ↑ When is a negative phase II trial truly negative? Am J Respir Crit Care Med 178(6):554-5 (2008) PMID 18755930
  2. ↑ The ethical conduct of clinical research involving critically ill patients in the United States and Canada: principles and recommendations. Am J Respir Crit Care Med 170(12):1375-84 (2004) PMID 15590885
  3. ↑ Positive clinical trials: understand the control group before implementing the result. Am J Respir Crit Care Med 170(3):223-6 (2004) PMID 15151921
  4. ↑ Number needed to treat and relative risk reduction. Ann Intern Med 128(1):72-3 (1998) PMID 9424990
  5. ↑ Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction. Ann Intern Med 123(11):873-7 (1995) PMID 7486471
  6. ↑ Understanding systematic reviews and meta-analysis. Arch Dis Child 90(8):845-8 (2005) PMID 16040886
  7. ↑ GRADE: levels of evidence and grades of recommendation. Arch Dis Child 89(5):489 (2004) PMID 15102650
  8. ↑ Statistics from the inside. 16. Multiple regression (2). Arch Dis Child 73(3):270-4 (1995) PMID 7492177
  9. ↑ Statistics from the inside. 13. Probability and decisions. Arch Dis Child 71(1):90-4 (1994) PMID 8067802
  10. ↑ 10. Counted data (2). Arch Dis Child 68(6):800-2 (1993) PMID 8333779
  11. ↑ Counted data (1). Arch Dis Child 68(2):246-9 (1993) PMID 8481051
  12. ↑ Statistics from the inside. 7. Regression and correlation. Arch Dis Child 67(10):1306-9 (1992) PMID 1444537
  13. ↑ Statistics from the inside. 6. Data structures (continued). Arch Dis Child 67(6):757-9 (1992) PMID 1626999
  14. ↑ Documenting research in scientific articles: Guidelines for authors: 3. Reporting multivariate analyses. Chest 131(2):628-32 (2007) PMID 17296672
  15. ↑ Documenting research in scientific articles: guidelines for authors: 2. Reporting hypothesis tests. Chest 131(1):317-9 (2007) PMID 17218594
  16. ↑ Documenting research in scientific articles: guidelines for authors: reporting research designs and activities. Chest 130(4):1263-8 (2006) PMID 17035466
  17. ↑ The design of randomized clinical trials in critically ill patients. Chest 121(4):1290-300 (2002) PMID 11948065
  18. ↑ Reality and meta-analyses. Chest 118(3):835-6 (2000) PMID 10988210
  19. ↑ Is meta-analysis a metaphysical or a scientific method? Chest 118(3):832-4 (2000) PMID 10988209
  20. ↑ Is meta-analysis really meta-physics? Chest 116(2):539-42 (1999) PMID 10453885
  21. ↑ Advice on statistical analysis for Circulation Research. Circ Res 91(8):662-71 (2002) PMID 12386142
  22. ↑ A primer in longitudinal data analysis. Circulation 118(19):2005-10 (2008) PMID 18981315
  23. ↑ Some old and some new statistical tools for outcomes research. Circulation 118(8):872-84 (2008) PMID 18711024
  24. ↑ Survival methods: additional topics. Circulation 117(22):2949-55 (2008) PMID 18519862
  25. ↑ Methods and limitations of assessing new noninvasive tests: Part II: Outcomes-based validation and reliability assessment of noninvasive testing. Circulation 117(21):2793-801 (2008) PMID 18506018
  26. ↑ Methods and limitations of assessing new noninvasive tests: part I: Anatomy-based validation of noninvasive testing. Circulation 117(20):2684-90 (2008) PMID 18490536
  27. ↑ Logistic regression. Circulation 117(18):2395-9 (2008) PMID 18458181
  28. ↑ Multiple linear regression: accounting for multiple simultaneous determinants of a continuous dependent variable. Circulation 117(13):1732-7 (2008) PMID 18378626
  29. ↑ Analysis of variance. Circulation 117(1):115-21 (2008) PMID 18172051
  30. ↑ Association studies in an era of too much information: clinical analysis of new biomarker and genetic data. Circulation 116(17):1866-70 (2007) PMID 17965399
  31. ↑ What exactly do the trends mean? Circulation 116(13):1437-9 (2007) PMID 17893285
  32. ↑ Meta-analysis. Circulation 115(22):2870-5 (2007) PMID 17548743
  33. ↑ Evaluation of randomized controlled trials. Circulation 115(13):1819-22 (2007) PMID 17404173
  34. ↑ Design of randomized controlled trials. Circulation 115(9):1164-9 (2007) PMID 17339574
  35. ↑ Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115(7):928-35 (2007) PMID 17309939
  36. ↑ Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 115(5):654-7 (2007) PMID 17283280
  37. ↑ Survival methods. Circulation 115(1):109-13 (2007) PMID 17200454
  38. ↑ Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation 113(3):456-62 (2006) PMID 16365198
  39. ↑ The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis. Circulation 109(21):e305-7 (2004) PMID 15173053
  40. ↑ The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design. Circulation 109(21):e302-4 (2004) PMID 15173052
  41. ↑ Interpreting results of clinical trials: a conceptual framework. Clin J Am Soc Nephrol 3(5):1246-52 (2008) PMID 18728215
  42. ↑ Systematic review and meta-analysis: when one study is just not enough. Clin J Am Soc Nephrol 3(1):253-60 (2008) PMID 18178786
  43. ↑ Practice recommendations based on low, very low, and missing evidence. Clin J Am Soc Nephrol 2(1):11-2 (2007) PMID 17699379
  44. ↑ Cohort studies: marching forward. Clin J Am Soc Nephrol 1(5):1117-23 (2006) PMID 17699334
  45. ↑ The meta-analysis: supportive or illuminating? Eur Heart J 27(23):2744-5 (2006) PMID 17107979
  46. ↑ Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials. Eur Heart J 27(18):2158-64 (2006) PMID 16870690
  47. ↑ Limitations of analyses of effectiveness using observational data. Eur Heart J 27(14):1642-3 (2006) PMID 16785246
  48. ↑ Interpretation of observational studies. Heart 90(8):956-60 (2004) PMID 15253985
  49. ↑ Absolute, attributable, and relative risk in the management of coronary heart disease. Heart 85(5):491-2 (2001) PMID 11302989
  50. ↑ Statistical issues in the analysis of neuronal data. J Neurophysiol 94(1):8-25 (2005) PMID 15985692
  51. ↑ The Bayesian clinician. J Postgrad Med 53(4):267-9 (2007) PMID 18097119
  52. ↑ Statistics in medical research--III. Correlation and regression analysis. J Postgrad Med 39(4):235-43 (1993) PMID 7996506
  53. ↑ Data extraction errors in meta-analyses that use standardized mean differences. JAMA 298(4):430-7 (2007) PMID 17652297
  54. ↑ How statistical expertise is used in medical research. JAMA 287(21):2817-20 (2002) PMID 12038922
  55. ↑ Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 286(7):821-30 (2001) PMID 11497536
  56. ↑ Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA 280(3):278-80 (1998) PMID 9676681
  57. ↑ Meta-analysis as a clinical tool in nephrology. Kidney Int 53(4):819-25 (1998) PMID 9551387
  58. ↑ Clinical research of kidney diseases IV: Standard regression models. Nephrol Dial Transplant 23(2):475-82 (2008) PMID 18182407
  59. ↑ P less than .05: what does it really mean? Pediatrics 119(3):608-10 (2007) PMID 17332213
  60. ↑ Data and models determine treatment proposals--an illustration from meta-analysis. Postgrad Med J 78(917):131-4 (2002) PMID 11884693
  61. ↑ Balancing statistical and clinical significance in evaluating treatment effects. Postgrad Med J 77(905):201-4 (2001) PMID 11222834
  62. ↑ Statistics in medicine: some considerations from a clinician's point of view. Postgrad Med J 74(876):577-8 (1998) PMID 10211346
  63. ↑ Potential bias in Kaplan-Meier survival analysis applied to rheumatology drug studies. Rheumatology (Oxford) 39(1):1-2 (2000) PMID 10662865
  64. ↑ When should you use statistics? Swiss Med Wkly 135(23-24):337-8 (2005) PMID 16059787
  65. ↑ Statistics in medical research. Swiss Med Wkly 133(39-40):522-9 (2003) PMID 14655052
  66. ↑ Statistics in medicine. Swiss Med Wkly 133(39-40):521 (2003) PMID 14655051
  67. ↑ Statistics in respiratory medicine. 3. Scale, parametric methods, and transformations. Thorax 46(7):536-8 (1991) PMID 1877042
  68. ↑ Statistics in respiratory medicine. 2. Repeatability and method comparison. Thorax 46(6):454-6 (1991) PMID 1858087
  69. ↑ A statistical evaluation of toxicity study designs for the estimation of the benchmark dose in continuous endpoints. Toxicol Sci 84(1):167-85 (2005) PMID 15483190
  70. ↑ Statistical issues in the analysis of low-dose endocrine disruptor data. Toxicol Sci 61(2):201-10 (2001) PMID 11353128
  71. ↑ Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology 44(5):1075-82 (2006) PMID 17058242
  72. ↑ Meta-analysis: an introduction and point of view. Hepatology 23(4):917-28 (1996) PMID 8666350
  73. ↑ Meta-analysis. J Am Coll Cardiol 52(3):237-8 (2008) PMID 18617074
  74. ↑ Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials. J Am Coll Cardiol 43(11):1929-39 (2004) PMID 15172393


Andere Lexika

Wikipedia kennt dieses Lemma (Statistik und Studiendesign) vermutlich nicht.

---


Abgerufen von „https://h.suprapedia.de/w/index.php?title=Statistik_und_Studiendesign&oldid=958397“